Immunologic parameters in chronic fatigue syndrome, major depression, and multiple sclerosis

American Journal of Medicine

Volumn 105, Issue 3 A, 1998, Pages 43S-49S

  Natelson, Benjamin H ^a   LaManca, John J ^b   Denny, Thomas N ^b   Vladutiu, Adrian ^b   Oleske, James ^b   Hill, Nancy ^b   Bergen, Michael T ^b   Korn, Leo ^b   Hay, John ^b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD28 ANTIGEN; CD38 ANTIGEN; CD45 ANTIGEN; COMPLEMENT COMPONENT C1Q; HLA DR ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M; LYMPHOCYTE ANTIGEN;

ADULT; ANTIGEN ANTIBODY COMPLEX; ANTIGEN EXPRESSION; ARTICLE; CHRONIC FATIGUE SYNDROME; COMPLEMENT FIXATION; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNE STATUS; IMMUNOGLOBULIN PRODUCTION; IMMUNOLOGICAL PARAMETERS; IMMUNOPATHOGENESIS; IMMUNOREGULATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; PRIORITY JOURNAL; RAJI CELL; SERODIAGNOSIS; SYMPTOMATOLOGY;

EID: 0032575943     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(98)00165-x     Document Type: Article

References (34)

1. Levy JA, Landay AL, Jessop C, Lennette E. Chronic fatigue syndrome: is it a state of chronic immune activation against an infectious virus? In: Root RK, Sande MA, eds. Viral Infections: Diagnosis, Treatment and Prevention. New York: Churchill Livingstone, 1992:127-144.
2. Lloyd AR, Wakefield D, Boughton CR, Dwyer JM. Immunological abnormalities in the chronic fatigue syndrome. Med J Aust. 1989;151:122-124.
3. Buchwald D, Komaroff AL. Review of laboratory findings for patients with chronic fatigue syndrome. Rev Infect Dis. 1991;13(suppl 1):S12-S18.
4. Rasmussen ÅK, Nielsen H, Andersen V, et al. Chronic fatigue syndrome - a controlled cross sectional study. J Rheumatol. 1994;21:1527-1531.
5. Bates DW, Buchwald D, Lee J, et al. Clinical laboratory test findings in patients with chronic fatigue syndrome. Arch Intern Med. 1995;155:97-103.
6. Landay AL, Jessop C, Lennette ET, Levy JA. Chronic fatigue syndrome: clinical condition associated with immune activation. Lancet. 1991;338:707-712.
7. Straus SE, Fritz S, Dale JK, Gould B, Strober W. Lymphocyte phenotype and function in the chronic fatigue syndrome. J Clin Immunol. 1993;13:30-40.
8. Gupta S, Vayuvegula B. A comprehensive immunological analysis in chronic fatigue syndrome. Scand J Immunol. 1991;33:319-327.
9. Fisk JD, Pontefract A, Ritvo PG, Archibald CJ, Murray TJ. The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci. 1994;21:9-14.
10. DeLuca J, Johnson SK, Ellis SP, Natelson BH. Cognitive functioning is impaired in chronic fatigue syndrome patients devoid of psychiatric disease. J Neurol Neurosurg Psychiatry. 1997;62:151-155.
11. Holmes GP, Kaplan JE, Gantz NM, et al. Chronic fatigue syndrome: a working case definition. Ann Intern Med. 1988; 108:387-389.
12. Fukuda K, Straus SE, Hickie I, et al. The chronic fatigue syndrome: A comprehensive approach to its definition and study. Ann Intern Med. 1994;121:953-959.
13. Natelson BH, Johnson SK, DeLuca J, et al. Reducing heterogeneity in chronic fatigue syndrome: a comparison with depression and multiple sclerosis. Clin Infect Dis. 1995;21: 1204-1210.
14. Marcus S, Robins LN, Bucholz K. Quick Diagnostic Interview Schedule 3R, version 1. St. Louis, MO: Washington University School of Medicine, 1990.
15. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983;13:227-231.
16. Kurtzke JF. Rating of neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33:1444-1452.
17. McNair DM, Lorr M, Droppleman LF. Profile of Mood States: Manual. San Diego: Educational and Industrial Testing Service, 1971.
18. Albini B, Fagundus AM, Vladutiu AC. Circulating immune complexes. In: Atassi MZ, Van Oss CJ, Absolom DR, eds. Molecular Immunology. New York: Marcel Dekker, 1984: 381-401.
19. Read R, Spickett G, Harvey J, Edwards AJ, Larson HE. IgG1 subclass deficiency in patients with chronic fatigue syndrome. Lancet. 1988;i:241-242.
20. Linde A, Smith CIE. IgG subclass deficiency and chronic fatigue syndrome. Lancet. 1988;i:885-886.
21. Bennett AL, Fagioli LR, Schur PH, Schacterle RS, Komaroff AL. Immunoglobulin subclass levels in chronic fatigue syndrome. J Clin Immunol. 1996;16:315-320.
22. Natelson BH, Ellis SP, O'Braoáin PJ, DeLuca J, Tapp WN. Frequency of deviant immunological test values in chronic fatigue syndrome patients. Clin Diagn Lab Immunol. 1995; 2:238-240.
23. Vollmer-Conna U, Hickie I, Hadzi-Pavlovic D, et al. Intravenous immunoglobulin is ineffective in the treatment of patients with chronic fatigue syndrome. Am J Med. 1997;103: 38-43.
24. Ho-Yen DO, Billington RW, Urquhart J. Natural killer cells and the post viral fatigue syndrome. Scand J Infect Dis. 1991;23:711-716.
25. Swanink CMA, Vercoulen JHMM, Galama JMD, et al. Lymphocyte subsets, apoptosis, and cytokines in patients with chronic fatigue syndrome. J Infect Dis. 1996;173:460-463.
26. Peakman M, Deale A, Field R, Mahalingam M, Wessely S. Clinical improvement in chronic fatigue syndrome is not associated with lymphocyte subsets of function or activation. Clin Immunol Immunopathol. 1997;82:83-91.
27. Mawle AC, Nisenbaum R, Dobbins JG, et al. Immune responses associated with chronic fatigue syndrome: a case-control study. J Infect Dis. 1997;175:136-141.
28. Shephard RJ, Rhind S, Shek PN. Exercise and the immune system: Natural killer cells, interleukins and related responses. Sports Med. 1994;18:340-369.
29. Pedersen BK, Ullum H. NK cell response to physical activity: possible mechanisms of action. Med Sci Sports Exerc. 1994;26:140-146.
30. Pepper CM, Krupp LB, Friedberg F, Doscher C, Coyle PK. A comparison of neuropsychiatric characteristics in chronic fatigue syndrome, multiple sclerosis, and major depression. J Neuropsychiatry Clin Neurosci. 1993;5:200-205.
31. Komaroff AL, Fagioli LR, Geiger AM, et al. An examination of the working case definition of chronic fatigue syndrome. Am J Med. 1996;100:56-64.
32. Rohowsky-Kochan C, Eiman D, Troiano R, et al. Decreased suppressor-inducer T lymphocytes in multiple sclerosis and other neurological diseases. J Neurol Sci. 1990;28:161-166.
33. Maes M, Lambrechts J, Bosmans E, et al. Evidence for a systemic immune activation during depression: results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining. Psychol Med. 1992;22: 45-53.
34. Tukey JW. Exploratory Data Analysis. Reading, MA: Addison-Wesley, 1977.